Cancer

The sBLA is based on results from the international, open-label Phase III DESTINY-Breast03 trial of Enhertu.

People treated with pembrolizumab lived for 17.1 months on average versus 11.6 months for chemotherapy, trial data showed.

Findings Hold Potential for Predicting Many Years in Advance Which Women With the BRCA-1 Mutation Will Develop Disease

As cancer cells mutate, some gain an advantage through mutations which make them more likely to survive, divide and create a group of ‘fitter’ cells. This group may outcompete others to become dominant, for example, if they have evolved to survive in conditions where there is a low supply of nutrients or oxygen.

Nearly 100% of cancer patients with solid tumours have antibodies effective against the Delta variant after a third dose of COVID-19 vaccine, according to new results published as a correspondence in Cancer Cell this week.

Life Took Christie Alkana Down a Dark Path. Her Cancer Journey Is Helping Her Thrive.

Around 240 million people around the world are infected with HBV. This virus is known to affect chromosomes in the liver and can cause hepatocellular cancer, the most common type of liver cancer. This process involves DNA from the virus being integrated into liver cells.

During Lung Cancer Awareness Month, Cedars-Sinai Highlights One-Day Turnaround Time